Cooley Achieves Top Marks in US, Global M&A Rankings

New York – January 8, 2024 – Cooley’s global mergers & acquisitions practice has been recognized based on its M&A activity on year-end M&A league tables from Bloomberg, Mergermarket and LSEG Data & Analytics (formerly known as Refinitiv). The recognitions are based on Cooley’s role in advising on more than 255 transactions globally announced in 2023, comprising more than $119 billion in deal volume for the year.

Led by co-chairs Jamie Leigh and Barbara Borden, Cooley’s M&A practice continues to dominate in public and private transactions in the US and globally – despite the unsettled M&A market.

Cooley’s top rankings include:

• Bloomberg, which ranked the firm #2 for global- and US-announced deals by deal count, as well as #2 for global- and US-announced deals – principals by deal count. Bloomberg also ranked Cooley as #1 for global mid-market deals and private equity deals, each by deal count, #2 for global- and US mid-market deals by deal value, and #1 for global private equity deals by deal value.
• Mergermarket, which ranked the firm #4 on its US league table by deal count and #5 on its global league table by deal count, as well as #3 for US private equity buyouts, #4 for global private equity buyouts by deal count, #3 for US private equity exits, and #4 for global private equity exits by deal value.

• LSEG, which ranked the firm #2 on its US league table for completed deals by deal count and #3 on its global league table for completed deals by deal count.

To support these rankings, Cooley handled deals across a diverse range of industries while also maintaining its top position in technology and life sciences. In 2023, the firm worked on multiple market-leading transactions, including representations of:

• RayzeBio in its $4.1 billion acquisition by Bristol Myers Squibb
• Carmot Therapeutics in its approximately $3 billion merger with Roche
• Insurance Auto Auctions in its $7.3 billion merger with Ritchie Bros.
• CinCor Pharma in its approximately $1.8 billion sale to AstraZeneca
• Gracell Biotechnologies in its approximately $1.2 billion sale to AstraZeneca
• VectivBio in its approximately $1 billion acquisition by Ironwood
• Amryt Pharma in its $1.48 billion sale to Chiesi Farmaceutici
• Zillow in its approximately $500 million acquisition of Follow Up Boss
• Absolute Software in its $870 million sale to Crosspoint Capital
• ThoughtSpot in its $200 million acquisition of Mode Analytics
• Sprout Social in its $140 million acquisition of Tagger Media and its previous acquisition of Repustate
• Bavarian Nordic in its $380 million acquisition of Emergent BioSolutions’ travel vaccines portfolio
• Uber in the $400 million sale of its 50% stake in a Careem super app to e&
• Definitive Healthcare in its acquisition of Populi
• TOYO Solar in its combination with Blue World Acquisition Corporation

Since 2019, Cooley’s world-class transactional team has worked on 1,540+ M&A deals for an aggregate value of more than $745 billion – guiding top public and private companies, financial advisers, and private equity sponsors in some of the market’s largest and most complex transactions. With the addition of a five-partner private equity and M&A team in Cooley’s Denver office in February 2023, the M&A group includes 180+ practitioners in major business and technology centers worldwide, representing all categories of participants in transactions.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has more than 1,300 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of nearly 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.